Skip to content

Effectiveness of injection hypertonic saline with furosemide

Effectiveness of continuous and intermittent injection of hypertonic saline with furosemide in reducing intracranial pressure in patients with brain injury using optic nerve diameter measurement; a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170903036041N7
Enrollment
75
Registered
2025-10-08
Start date
2025-10-18
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with decreased intracranial pressure. Cerebral edema due to birth injury

Interventions

Intervention 1: Intervention group: Continuous infusion of 5% hypertonic saline, half a milliliter per kilogram per hour, along with furosemide, half a milligram per kilogram, over 24 hours for three

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diagnosis of increased intracranial pressure based on clinical reports and tests Optic nerve diameter greater than 5.5 millimeter on initial ultrasound evaluation State of consciousness above 4 Age 18 to 70 years

Exclusion criteria

Exclusion criteria: Pregnancy Kidney failure or need for dialysis Coagulation disorders or serum sodium above 150 Milliequivalents per liter on admission Hypotension requiring vasopressors to maintain mean blood pressure above 60 Heart failure less than 40% Eye tear or injury Patients with pulmonary edema During the study, sodium levels above 160 Milliequivalents per liter

Design outcomes

Primary

MeasureTime frame
Intracranial pressure. Timepoint: Upon admission, 24, 48, and 72 hours after the start of treatment. Also 24 and 48 hours after the end of treatment. Method of measurement: Measurement using optic nerve diameter.

Secondary

MeasureTime frame
Level of consciousness. Timepoint: Every day during the intervention (for three days). Method of measurement: Glasgow coma scale.;Hemodynamic level. Timepoint: Every day during the intervention (for three days). Method of measurement: Your blood pressure, heart rate, and urine volume will be checked.;Serum sodium and potassium. Timepoint: Every six hours for three days. Method of measurement: Laboratory findings report.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOmid Moradimoghadam

Iran University of Medical Sciences

moradimoghadam.o@iums.ac.ir+98 21 6435 2255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026